Activities
- Strategies to Address Misconceptions and Educate Parents and Patients on HPV-vaccination
- Approaches to Acute Iliofemoral Deep Vein Thrombosis: Medical and Endovascular Management
- Decisions in Interventional Management of Acute Pulmonary Embolism
- Closing in on Post-Thrombotic Syndrome: The Latest Updates
- Improving Outcomes in Chronic Limb-threatening Ischemia: Practical Approaches to Above- and Below-the-knee Interventions
- Maximizing Current Therapies and Exploring Future Directions as PARP Inhibitors Take the Stage in Prostate Cancer
- Reducing Healthcare Disparities for PAH Patients
- PAH and COVID-19: A Patient’s Journey
- Race, Ethnicity, and Breast Cancer: Health Equity Panel Discussion
- Leading the Way: Improving Breast Cancer Disparities for Minority Patients in Chicago
- From Risk Assessment to Treatment: Real-World Approaches to PAH
- A Closer Look at PAH Diagnosis, Screening, and Risk Assessment
- Oral Combination Therapy: The PAtH to Improved Patient Care in PAH
- Hot Topics in PAH: What We’ve Learned in the Past Year
- Practical Considerations for Patients with PAD Post-Revascularization
- Postdischarge Thromboprophylaxis for Acutely Ill Medical Patients
- What Every Clinician Needs to Know About COVID-19 and Thrombosis
- Who’s On The Tightrope? Understanding Patients With Chronic Polyvascular Disease
- On A Limb: How Can We Better Optimize PAD Care?
- DOACs in Transition: Examining the Challenges and Complexity of Transitions in Care
- Late-breaking Science with DOACs and Implications for Patient Care
- Highlights from the 12th Annual Linda Morgante MS Nurse Leadership Program
- Polyvascular Patients: Are You Doing Enough to Reduce Risk of Recurrent Events?
- Interpretation of ECHO and the Path to Diagnostic Certainty in PAH
- The ABCs of CTD-PAH: (A)lgorithms, Team - (B)ased Approach, and (C)ombination Therapy
- RCC Treatment Strategies in a Poor-Risk Patient
- RCC Treatment Strategies in a Favorable-Risk Patient
- Real-World Perspectives on the Role of TYK2 Inhibitors in the Treatment of Psoriasis
- Improving the Prognosis for Patients with BRAF-mutant and/or MSI-H mCRC
- Considerations for Antimicrobial Selection in Clostridioides difficile Infection
- Tryptase Testing: Clinical Utility and Application During COVID-19 Vaccination Reactions
- Tryptase Testing in Chronic Mast Cell Disorders and Acute Settings
- Complex Chronic Deep Venous Disease: A Multidisciplinary Discussion
- Case Challenges in Patients With EGFR-Mutant NSCLC
- Identifying Actionable Markers to Guide Therapy for Patients With EGFR-Mutant NSCLC
- Highlights from Kidney Week
- Latest Data in FSGS and IgAN
- Highlights in FSGS and IgAN
- Kidney Week Conference Coverage
- DOACs Post-Revascularization - Can We Decrease Major Adverse Limb Events (MALE) and Improve Outcomes?
- A Next Generation of Pneumococcal Disease Protection
- Practical Tools & Expert Guidance for the Nurse Navigator and Clinical Team: Strategies to Reduce Treatment Disparities in Multiple Myeloma
- Telling the Story of IBD: Helping Patients Understand the Promise of New Therapies
- T2DM Management in Primary Care Practice: Addressing the Weight of it All
- Clinical Inertia Assessment Tool
- Host a Visiting Professorship Program
- PFF Summit Highlights: News You Can Use
- Answering the Call: Strategies to Maximize Preventive Health Maintenance for Underrepresented IBD Patient Populations
- Next Generation Pneumococcal Vaccines: What You Need to Know
- Checkpoint Blockade in the Adjuvant and Neoadjuvant Settings: Key Considerations for the Surgical Oncologist
- Shots in the Dark: How Can Clinicians Bridge the Immunization Gaps Widened by the COVID-19 Pandemic?
- Multidisciplinary Viewpoints on NTM-LD Diagnosis and Management
- Real-World Experience in Diagnosing and Managing PNH in Special Patient Populations
- Answering the Call: Nurse-Led Strategies to Improve Compliance with Hemophilia Prophylaxis
- Pathways to Transfusion Independence & Reduced Health Complications: Advances for Lower-Risk MDS
- Practical Guidance for the Community Oncologist — Incorporating Advances in Therapy for Metastatic TNBC: A Focus on TROP2
- Hard to Swallow, Pharmacist-Led Strategies to Improve EoE Care
- Get It Right the First Time: Selection of Antimicrobial Therapy for C. difficile
- Patient-Centered Approaches to Treatment and Prevention of Clostridioides difficile Infection
- Beyond the Procedure: Evolving the Current Standard of Care for Patients with PAD
- LET'S BE BLUNT: Collaborating With Patients With Major Depressive Disorder to Achieve Full Functional Recovery
- LET'S BE BLUNT: Collaborating With Patients With Major Depressive Disorder to Achieve Full Functional Recovery
- Matching Treatment to Mutations: Clinical Pathways to Optimize RET+ Testing in NSCLC and Thyroid Cancer
- Listen to Me! Helping Women Talk to Their Healthcare Provider About Hot Flashes
- Sounding the Alarm: Protecting PAD Patients Post Revascularization from Recurrent Events
- Diagnostic Pathways for Alzheimer’s Disease: Optimizing Multidisciplinary Practices
- Are You Ready? DOACs for Pediatric Patients with Venous Thromboembolism
- New Possibilities for Maintenance Therapy in AML
- Individualizing Prostate Cancer Treatment: Special Considerations for Gay and Bisexual Men
- Spotlight on IRON CLAD: Clinical Review of IV Iron Replacement Therapy for Cancer- and Chemotherapy-Induced Anemia
- A New Era: Targeting Iron Deficiency to Improve Heart Failure Outcomes
- Menopause Matters…Let’s Start Paying Attention to Racial and Ethnic Differences
- Bringing Expert Care to the Community: Precision Medicine for Pediatric and Adult Patients With SBS
- Precision Medicine for All: Strategies for Meaningful and Sustainable Improvements to Reduce Health Disparities in NSCLC
- All in for ALL: Mitigating VOD Risk in Patients Being Treated for R/R ALL
- Initial Therapy Matters for Clostridioides difficile – Get it Right the First Time
- Early-Stage TNBC: What are the Roles of PARPIs?
- TNBC Case Challenges. Test Your Treatment Skills!
- Where do Anti-TROP2 ADCs Factor into Advanced TNBC Care?
- Differentiating Early Signs of Alzheimer Disease From Normal Signs of Aging and Determining Best Next Steps
- Keeping Up the Pace in IBD: Adaptive Learning to Optimize Therapeutic Decision-Making for Patients with UC and CD
- New Paths for Targeting the Complement System: Addressing Unmet Needs in Paroxysmal Nocturnal Hemoglobinuria
- Recurring Problems, New Solutions: Interrupting the Cycle of Recurrence in Clostridioides difficile Infection
- Community Conversations: Real-World Strategies for Overcoming Disparities in Immunotherapy Cancer Care
- Lessons Learned and New Opportunities: Strategies for Meaningful and Sustainable Improvements to Reduce Health Disparities in Prostate Cancer
- Practical Solutions to Prevent and Prepare for Severe Hypoglycemia
- Diagnosing and Treating Women with IDA: What Every Clinician Needs to Know
- Eosinophilic Esophagitis (EoE) Essentials for the Multidisciplinary Provider Team
- Showing Patients with Migraine the Possibilities with CGRP mAbs
- Emerging Strategies for Optimizing and Simplifying the Management of Resistant Hypertension
- CME Brief: Clinical Insights on Monkeypox
- Breaking the Cycle: The Role of Microbiota-Based Biotherapies in the Reduction of Recurrent Clostridioides difficile
- Exploring Emerging Therapeutic Opportunities for Menopausal Women with Autoimmune Disease
- Evolving Recommendations and Strategies for Vaccine Selection in Populations at Risk for Severe Influenza-related Illness
- A New Path Forward: The Therapeutic Potential of Next Generation BTK Inhibitors in CLL/SLL
- In the Driver’s Seat with Multiple Sclerosis: Optimizing DMT Selection
- Sending out an SOS: Best Practices for Returning Patients with SOS/VOD on the Road to Cure
- Ready, Set, Action: Collaborative Management to Improve Diagnosis of Alzheimer Disease
- Collaborative Management Strategies for Acute/Urgent Care in Short Bowel Syndrome
- A New Path Forward: The Therapeutic Potential of Next Generation BTK Inhibitors in CLL/SLL
- Bringing Expert Care to the Community: Precision Medicine for Pediatric and Adult Patients With SBS
- Mitigating Veno-occlusive Disease Risk in Patients Treated for Relapsed/Refractory B-cell Precursor ALL
- Improving Screening and Early Diagnosis of Alpha-1 Antitrypsin Deficiency (AATD): Why Is the Unacceptable, Acceptable?
- Pathways to Developing Personalized Treatment Regimens for Patients with Advanced Melanoma
- Ensuring Gender-Affirming Health Care for Transgender and Gender-Diverse Youth
- Patients are Talking: Change is Needed in How We Manage Endometriosis
- Addressing the Barriers to Medical Treatment for Alcohol Use Disorder (AUD)
- New Conversations About Long-Acting Reversible Contraceptives: Patient Stories and Expert Reflections
- Parenteral Nutrition Solutions: Developing a Playbook for the Multidisciplinary Team
- Adaptive Learning to Improve Individualized Management of Type 2 Diabetes (T2D)
Series
external activities
Therapeutic Areas
User Profile
